Bipolar and Related Disorders

Not specified

• Sanofi-Aventis — Paris, France

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Aichi, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Akita, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Chiba, Japan
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Fukuoka, Japan

• Research Site — Aarschot, Belgium
• Research Site — Afsnee, Belgium
• Research Site — Antwerp, Belgium
• Research Site — Asse, Belgium

• Research Site — Vitoria-Gasteiz, Alava, Spain
• Research Site — Palma, Balearic Islands, Spain
• Research Site — Gavà, Barcelona, Spain
• Research Site — Burgos, Spain

• Research Site — Almelo, Netherlands
• Research Site — Alphen Aan de Rigjn, Netherlands
• Research Site — Amersfoort, Netherlands
• Research Site — Amstelveen, Netherlands

• Research Sites — Beijing, China
• Research Site — Guangzhou, China
• Research Site — Kunming, China
• Research Site — Nanjing, China

• Research Site — A Coruña, Spain
• Research Site — Alcoy, Spain
• Research Site — Algeciras, Spain
• Research Site — Almería, Spain

• Cambridge Health Alliance — Medford, Massachusetts, United States

Not specified